AUB ScholarWorks

Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.

Show simple item record Rahal E.A. Kazzi N. Nassar F.J. Matar G.M.
dc.contributor.editor Dec-2012 2017-10-05T15:35:28Z 2017-10-05T15:35:28Z 2012
dc.identifier 10.3389/fcimb.2012.00138
dc.identifier.issn 22352988
dc.description.abstract Escherichia coli O157:H7 is a notorious pathogen often contracted by intake of contaminated water or food. Infection with this agent is associated with a broad spectrum of illness ranging from mild diarrhea and hemorrhagic colitis to the potentially fatal hemolytic uremic syndrome (HUS). Treating E. coli O157:H7 infection with antimicrobial agents is associated with an increased risk of severe sequelae such as HUS. The difficulty in treating this bacterium using conventional modalities of antimicrobial agent administration has sparked an interest in investigating new therapeutic approaches to this bacterium. These approaches have included the use of probiotic agents and natural products with variable success rates. In addition, novel modalities and regimen of antimicrobial agent administration have been assessed in an attempt at decreasing their association with aggravating infection outcomes.
dc.language English
dc.publisher LAUSANNE
dc.relation.ispartof Publication Name: Frontiers in cellular and infection microbiology; Publication Year: 2012; Volume: 2; Pages: (138
dc.source Scopus
dc.title Escherichia coli O157:H7-Clinical aspects and novel treatment approaches.
dc.type Review
dc.contributor.affiliation Rahal, E.A., Faculty of Medicine, Department of Experimental Pathology, Immunology and Microbiology, American University of Beirut Beirut, Lebanon.
dc.contributor.affiliation Kazzi, N.
dc.contributor.affiliation Nassar, F.J.
dc.contributor.affiliation Matar, G.M.
dc.contributor.authorAddress Rahal, E.A.
dc.contributor.authorCorporate University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Experimental Pathology, Immunology and Microbiology;
dc.contributor.authorDepartment Experimental Pathology, Immunology and Microbiology
dc.contributor.authorFaculty Faculty of Medicine
dc.contributor.authorInitials Rahal, EA
dc.contributor.authorInitials Kazzi, N
dc.contributor.authorInitials Nassar, FJ
dc.contributor.authorInitials Matar, GM
dc.contributor.authorReprintAddress Matar, GM (reprint author), Amer Univ Beirut, Fac Med, Dept Expt Pathol Immunol and Microbiol, POB 11-0236, Beirut 11072020, Lebanon.
dc.contributor.authorUniversity American University of Beirut Medical Center
dc.description.cited Armstrong GL, 1996, EPIDEMIOL REV, V18, P29; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128-IAI.72.4.2240-2247.2004; Bell BP, 1997, PEDIATRICS, V100, part. no., DOI 10.1542-peds.100.1.e12; BELONGIA EA, 1993, JAMA-J AM MED ASSOC, V269, P883, DOI 10.1001-jama.269.7.883; Betz J, 2011, J LIPID RES, V52, P618, DOI 10.1194-jlr.M010819; Bopp DJ, 2003, J CLIN MICROBIOL, V41, P174, DOI 10.1128-JCM.41.1.174-180.2003; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056-NEJM199508103330608; Brandl MT, 2008, APPL ENVIRON MICROB, V74, P5285, DOI 10.1128-AEM.01073-08; Brunder W, 1997, MOL MICROBIOL, V24, P767, DOI 10.1046-j.1365-2958.1997.3871751.x; CALDERWOOD SB, 1987, P NATL ACAD SCI USA, V84, P4364, DOI 10.1073-pnas.84.13.4364; Caprioli A, 2005, VET RES, V36, P289, DOI 10.1051-vetres:2005002; CIMOLAI N, 1994, CLIN NEPHROL, V42, P85; DeVinney R, 1999, INFECT IMMUN, V67, P2389; Diaz S, 2011, FOODBORNE PATHOG DIS, V8, P1313, DOI 10.1089-fpd.2011.0923; Donohue-Rolfe A, 1999, INFECT IMMUN, V67, P3645; Doyle M. P., 2001, FOOD MICROBIOLOGY FU; Etienne-Mesmin L, 2011, APPL ENVIRON MICROB, V77, P1127, DOI 10.1128-AEM.02130-10; Friedman MS, 1999, CLIN INFECT DIS, V29, P298, DOI 10.1086-520204; Gagnon M, 2006, INT J FOOD MICROBIOL, V111, P26, DOI 10.1016-j.ijfoodmicro.2006.04.041; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; GIANANTONIO CA, 1964, J PEDIATR, V64, P478, DOI 10.1016-S0022-3476(64)80337-1; GRIFFIN PM, 1988, ANN INTERN MED, V109, P705; GRIFFIN PM, 1994, INT CONGR SER, V1072, P7; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60; Hilborn ED, 1999, ARCH INTERN MED, V159, P1758, DOI 10.1001-archinte.159.15.1758; HOFMANN SL, 1993, AM J MED SCI, V306, P398, DOI 10.1097-00000441-199312000-00009; ITO H, 1990, MICROB PATHOGENESIS, V8, P47, DOI 10.1016-0882-4010(90)90007-D; JACKSON MP, 1990, MICROB PATHOGENESIS, V8, P235, DOI 10.1016-0882-4010(90)90050-Z; Kanbar A., 2003, J APPL RES, V3, P137; KARMALI MA, 1983, LANCET, V2, P1299; Kataoka Y, 2010, J VET MED SCI, V72, P791; KEENE WE, 1994, NEW ENGL J MED, V331, P579, DOI 10.1056-NEJM199409013310904; Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016-j.bbrc.2008.12.053; Kimmitt PT, 2000, EMERG INFECT DIS, V6, P458; Kresse AU, 2000, J BACTERIOL, V182, P6490, DOI 10.1128-JB.182.22.6490-6498.2000; Kresse AU, 1998, J BACTERIOL, V180, P4370; Kudva IT, 1998, APPL ENVIRON MICROB, V64, P3166; Lacombe A, 2010, INT J FOOD MICROBIOL, V139, P102, DOI 10.1016-j.ijfoodmicro.2010.01.035; Lee KM, 2009, J FOOD PROTECT, V72, P325; Lengacher B, 2010, J FOOD PROTECT, V73, P2089; LEVINE MM, 1987, J INFECT DIS, V155, P377; Lopez EL, 2010, ANTIMICROB AGENTS CH, V54, P239, DOI 10.1128-AAC.00343-09; LOUIE M, 1993, INFECT IMMUN, V61, P4085; Low AS, 2006, ENVIRON MICROBIOL, V8, P1033, DOI 10.1111-j.1462-2920.2006.00995.x; Matar GM, 2003, ANN TROP MED PARASIT, V97, P281, DOI 10.1179-000349803235002146; McDowell D. A., 2001, VEROCYTOTOXIGENIC ES, P279; McLigeyo SO, 1999, E AFR MED J, V76, P148; Mead PS, 1998, LANCET, V352, P1207, DOI 10.1016-S0140-6736(98)01267-7; Mead PS, 1999, EMERG INFECT DIS, V5, P607; Melton-Celsa AR, 1998, ESCHERICHIA COLI O15, P121; Melton-Celsa AR, 2002, MOL MICROBIOL, V43, P207, DOI 10.1046-j.1365-2958.2002.02733.x; Mersha G, 2010, LETT APPL MICROBIOL, V50, P71, DOI 10.1111-j.1472-765X.2009.02757.x; Meyers KEC, 2000, KIDNEY INT, V57, P2650, DOI 10.1046-j.1523-1755.2000.00126.x; Michino H, 1999, AM J EPIDEMIOL, V150, P787; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142; Nauschuetz W, 1998, Clin Lab Sci, V11, P298; Nishikawa K, 2002, P NATL ACAD SCI USA, V99, P7669, DOI 10.1073-pnas.112058999; OBRIEN AD, 1987, MICROBIOL REV, V51, P206; Ogawa M, 2001, INFECT IMMUN, V69, P1101, DOI 10.1128-IAI.69.2.1101-1108.2001; Ogierman MA, 2000, INFECT IMMUN, V68, P5344, DOI 10.1128-IAI.68.9.5344-5353.2000; Olsen SJ, 2002, EMERG INFECT DIS, V8, P370; Orth D, 2010, INFECT IMMUN, V78, P4294, DOI 10.1128-IAI.00488-10; Oussalah M, 2006, J FOOD PROTECT, V69, P1046; PAI CH, 1988, J INFECT DIS, V157, P1054; Panaro L, 1990, Can Dis Wkly Rep, V16, P90; Paunio M, 1999, EPIDEMIOL INFECT, V122, P1, DOI 10.1017-S0950268898001927; Pruimboom-Brees IM, 2000, P NATL ACAD SCI USA, V97, P10325, DOI 10.1073-pnas.190329997; Qadri SMH, 1998, POSTGRAD MED, V103, P179; RAGHUBEER EV, 1990, J CLIN MICROBIOL, V28, P803; Rahal EA, 2011, INT J ANTIMICROB AG, V37, P135, DOI 10.1016-j.ijantimicag.2010.10.009; Rahal EA, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186-1476-0711-10-34; Rangel JM, 2005, EMERG INFECT DIS, V11, P603; MARCH SB, 1986, J CLIN MICROBIOL, V23, P869; REIDA P, 1994, ZBL BAKT-INT J MED M, V281, P534; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056-NEJM198303243081203; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001-jama.288.8.996; Sandvig K, 1996, PHYSIOL REV, V76, P949; Sato T, 2003, J BACTERIOL, V185, P3966, DOI 10.1128-JB.185.3966-3971.2003; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128-AEM.66.3.1205-1208.2000; Schmidt H, 1996, MICROBIOL-UK, V142, P907; Shimizu T, 2009, INFECT IMMUN, V77, P2813, DOI 10.1128-IAI.00060-09; Shu Q, 2001, MED MICROBIOL IMMUN, V189, P147, DOI 10.1007-s430-001-8021-9; Shu Q, 2002, FEMS IMMUNOL MED MIC, V34, P59, DOI 10.1016-S0928-8244(02)00340-1; Siegler RL, 1995, PEDIATR CLIN N AM, V42, P1505; Slutsker L, 1997, ANN INTERN MED, V126, P505; Smith KE, 2012, PEDIATR INFECT DIS J, V31, P37, DOI 10.1097-INF.0b013e31823096a8; STROCKBINE NA, 1986, INFECT IMMUN, V53, P135; SWERDLOW DL, 1992, ANN INTERN MED, V117, P812; Tahamtan Y, 2011, LETT APPL MICROBIOL, V52, P527, DOI 10.1111-j.1472-765X.2011.03037.x; Takahashi M, 2004, FEMS IMMUNOL MED MIC, V41, P219, DOI 10.1016-j.femsim.2004.03.010; TESH VL, 1992, MICROB PATHOGENESIS, V12, P245, DOI 10.1016-0882-4010(92)90043-N; Urdahl AM, 2003, J APPL MICROBIOL, V95, P92, DOI 10.1046-j.1365-2672.2003.01964.x; Vallance BA, 2000, P NATL ACAD SCI USA, V97, P8799, DOI 10.1073-pnas.97.16.8799; van Gorp ECM, 1999, J INFECT DIS, V180, P176, DOI 10.1086-314829; Wang GD, 1998, J FOOD PROTECT, V61, P662; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056-NEJM200006293422601; Xicohtencati-Cortes J, 2007, J CLIN INVEST, V117, P3519, DOI 10.1172-JC130727; Yoh M, 1997, FEMS IMMUNOL MED MIC, V19, P57, DOI 10.1111-j.1574-695X.1997.tb01072.x; Zhang QS, 2009, J INFECT DIS, V199, P486, DOI 10.1086-596509; Zheng J, 2008, APPL ENVIRON MICROB, V74, P5645, DOI 10.1128-AEM.00503-08
dc.description.citedCount 1
dc.description.citedTotWOSCount 4
dc.description.citedWOSCount 4
dc.format.extentCount -137
dc.identifier.pubmedID 23162800
dc.identifier.scopusID 84878085754
dc.publisher.address PO BOX 110, LAUSANNE, 1015, SWITZERLAND
dc.relation.ispartOfISOAbbr Front. Cell. Infect. Microbiol.
dc.relation.ispartofPubTitle Frontiers in cellular and infection microbiology
dc.relation.ispartofPubTitleAbbr Front Cell Infect Microbiol
dc.relation.ispartOfVolume 2
dc.source.ID WOS:000324638100007
dc.type.publication Journal
dc.subject.otherChemCAS Shiga toxin, 75757-64-1
dc.subject.otherChemCAS Anti-Infective Agents
dc.subject.otherChemCAS Biological Products
dc.subject.otherIndex antiinfective agent
dc.subject.otherIndex biological product
dc.subject.otherIndex probiotic agent
dc.subject.otherIndex Shiga toxin
dc.subject.otherIndex antimicrobial chemotherapy
dc.subject.otherIndex diarrhea
dc.subject.otherIndex Escherichia coli infection
dc.subject.otherIndex Escherichia coli O157
dc.subject.otherIndex Escherichia coli O157:H7
dc.subject.otherIndex hemolytic uremic syndrome
dc.subject.otherIndex hemorrhagic colitis
dc.subject.otherIndex human
dc.subject.otherIndex microbiology
dc.subject.otherIndex pathogenicity
dc.subject.otherIndex pathology
dc.subject.otherIndex review
dc.subject.otherIndex treatment outcome
dc.subject.otherIndex antimicrobial chemotherapy
dc.subject.otherIndex Escherichia coli O157:H7
dc.subject.otherIndex hemolytic uremic syndrome
dc.subject.otherIndex hemorrhagic colitis
dc.subject.otherIndex shiga toxins
dc.subject.otherIndex Anti-Infective Agents
dc.subject.otherIndex Biological Products
dc.subject.otherIndex Diarrhea
dc.subject.otherIndex Escherichia coli Infections
dc.subject.otherIndex Escherichia coli O157
dc.subject.otherIndex Hemolytic-Uremic Syndrome
dc.subject.otherIndex Humans
dc.subject.otherIndex Probiotics
dc.subject.otherIndex Treatment Outcome
dc.subject.otherKeywordPlus HEMOLYTIC-UREMIC SYNDROME
dc.subject.otherKeywordPlus SHIGA-LIKE TOXINS
dc.subject.otherKeywordPlus SWIMMING-ASSOCIATED OUTBREAK
dc.subject.otherKeywordPlus O157-H7 INFECTION
dc.subject.otherKeywordPlus HEMORRHAGIC COLITIS
dc.subject.otherKeywordPlus ANTIBIOTIC-TREATMENT
dc.subject.otherKeywordPlus WATERBORNE OUTBREAK
dc.subject.otherKeywordPlus UNITED-STATES
dc.subject.otherKeywordPlus SEROTYPE O157-H7
dc.subject.otherKeywordPlus SERINE-PROTEASE
dc.subject.otherWOS Immunology
dc.subject.otherWOS Microbiology

Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search AUB ScholarWorks


My Account